Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating hemolytic anemia and application thereof

A technology of hemolytic anemia, composition, applied in the field of traditional Chinese medicine, capable of solving problems such as incurable diseases, structural and functional changes, failure and shock

Pending Publication Date: 2021-06-18
马宇振
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

When hemolytic anemia occurs, the red blood cells die prematurely; the insufficient number of healthy red blood cells in the body will gradually lead to the symptoms of hypoxia in the body. If it is not treated in time, the organs of the whole body will gradually lose their normal functions, and even failure and shock will occur, which is fatal. ;Symptoms of acute hemolytic anemia mainly include fatigue, weakness; severe pain in the back and limbs; headache, vomiting; chills, fever; pallor; , acute kidney failure; shock, and even death; common clinical symptoms of chronic hemolytic anemia include feeling tired easily; difficulty concentrating; pale skin; feeling dizzy when standing up; shortness of breath; jaundice (yellowing of the skin and eyes); If it is not effectively treated, it will cause enlargement of the liver and spleen; cholelithiasis; liver function damage; bone deformation, significant changes in structure and function; may induce aggravation of hemolysis, and hemolytic crisis; the main treatment policy for hemolytic anemia in Western medicine Yes: No treatment for mild cases. In severe cases, blood transfusion and fluid replacement, or hormone and immune preparations are given for treatment. If the above treatment methods continue to fail to improve, surgical treatment with splenectomy is used; splenectomy cannot cure the disease, only It can alleviate the condition to varying degrees; from the above content, it can be seen that Western medicine has no direct and effective way to treat hemolytic anemia, especially in the later stage, splenectomy not only makes the patient suffer great pain, but also needs to pay high treatment costs; for the treatment of traditional Chinese medicine The method is not recognized by most Chinese medicine experts. The reason is that the commonly used prescriptions such as Yinchen Dazao are not effective in treatment, and such as Renshen Guipi Pills, which only play an auxiliary therapeutic role and need to cooperate with Western medicine; The treatment principles of chronic anemia mainly include invigorating the spleen and stomach, nourishing blood and invigorating qi, clearing away dampness and reducing fever, or diuresis to stimulate menstruation, resulting in poor treatment effect and inability to eradicate the disease

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] A pharmaceutical composition for treating hemolytic anemia, which comprises the following raw materials prepared in parts by weight: 2 parts of Radix Aconiti, 10 parts of Cistanche, 2 parts of Epimedium, 10 parts of Morinda officinalis, and 6 parts of Coptidis , 10 parts of Scutellaria baicalensis, 2.5 parts of Cortex Phellodendri, 8 parts of Plantago, 31 parts of Imperata Rhizome, 5 parts of Gardenia.

Embodiment 2

[0037] A pharmaceutical composition for treating hemolytic anemia, which comprises the following raw materials prepared in parts by weight: 15.1 parts of Radix Aconiti, 5.5 parts of Herba Cistanche, 10 parts of Epimedium, 2.5 parts of Morinda officinalis, and 1.5 parts of Coptis Rhizoma , 2.5 parts of Scutellaria baicalensis, 13 parts of Cortex Phellodendri, 16 parts of Plantago, 8 parts of Imperata Rhizome, 10 parts of Gardenia.

Embodiment 3

[0039] A pharmaceutical composition for treating hemolytic anemia, which comprises the following raw materials formulated in parts by weight: 3 parts of Radix Aconiti, 9 parts of Cistanche, 9 parts of Epimedium, 3 parts of Morinda officinalis, and 2 parts of Coptidis , 3 parts of Scutellaria baicalensis, 3 parts of Cortex Phellodendri, 9 parts of Plantago, 9 parts of Imperata Rhizome, 6 parts of Gardenia.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to a pharmaceutical composition for treating hemolytic anemia and application thereof. The pharmaceutical composition is prepared from the following raw materials: processed radix aconiti lateralis, herba cistanche, herba epimedii, radix morindae officinalis, rhizoma coptidis, radix scutellariae, cortex phellodendri, semen plantaginis, rhizoma imperatae and fructus gardeniae. The pharmaceutical composition has the advantages of stable quality control and obvious treatment effect, can warm and invigorate kidney yang to help the spleen and the stomach to decompose food, can enable the spleen transportation function to be normal and block the damp-heat source, can clear damp-heat to achieve the effect of treating both symptoms and root causes, and has high cure rate.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to a pharmaceutical composition for treating hemolytic anemia and its application. Background technique [0002] Hemolytic anemia refers to anemia caused by the destruction of red blood cells in the human body faster than the compensatory ability of the bone marrow to form hematopoiesis. The average lifespan of red blood cells is about 120 days, during which time they supply oxygen to various organs of the body through blood circulation. When hemolytic anemia occurs, the red blood cells die prematurely; the insufficient number of healthy red blood cells in the body will gradually lead to the symptoms of hypoxia in the body. If it is not treated in time, the organs of the whole body will gradually lose their normal functions, and even failure and shock will occur, which is fatal. ;Symptoms of acute hemolytic anemia mainly include fatigue, weakness; s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/899A61P7/06
CPCA61K36/296A61K36/539A61K36/64A61K36/68A61K36/714A61K36/718A61K36/744A61K36/746A61K36/756A61K36/899A61P7/06A61K2300/00
Inventor 马宇振马医博邢盼盼马俊鹏马腾飞
Owner 马宇振
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products